ERBB2 and breast cancer: PDS models have been chosen to represent a broad range of luminal BC cells, including the ER + /HER2- MCF7, T47D, and ZR751, two endocrine resistant derivatives of MCF7, the EDR and TamR, and two ER + /HER2+ models, the BT474 and MDAMB361.